Views & Analysis Jay Bradner: leading Novartis into age of digitally-enabled ... Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into 'a medicine and data science company'.
Views & Analysis How AI, blockchain, and big data can reduce drug development... Cutting-edge technologies are increasingly improving pharma’s R&D processes.
News Medial EarlySign's AI scans medical records for kidney disea... A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
News Nearly half of life science professionals using AI - survey But lack of technical expertise holding back projects.
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
News Chai raises $130m for AI drug discovery platform AI specialist Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B financing.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.